Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
April 12, 2004
- CMIC MPSS Focusing on Subject Recruitment, Education, Training
April 12, 2004
- Sweeping Revision of OTC Drug Marketing Regulations to Be Discussed
April 12, 2004
- Companies Welcome Newcomers
April 12, 2004
- OTC NEWS IN BRRIEF
April 12, 2004
- Informed Choice Better than Informed Consent: JPMA Consumer Survey
April 12, 2004
- Japanese Healthcare Q&A (7)
April 12, 2004
- BUSINESS NEWS IN BRIEF -1-
April 12, 2004
- DIAGNOSTIC NEWS IN BRIEF
April 12, 2004
- BUSINESS NEWS IN BRIEF -2-
April 12, 2004
- WORLD NEWS IN BREIF
April 12, 2004
- Harnal, Lipitor, Micardis Show Continued Growth: Yamanouchi
April 12, 2004
- 57% of Drug Makers Asked to Change Products' Appearance to Prevent Accidents
April 12, 2004
- NEW PRODUCTS
April 12, 2004
- More than 30% of Drug Companies Not Compliant with GPMSP: Korosho Survey
April 12, 2004
- METI to Promote Training of Human Resources for Biotech Industry
April 12, 2004
- Contract Mfg Now Accounts for Half of Sales: Nipro Pharma
April 5, 2004
- JMA Announces Report on Medical Practices, Bioethics
April 5, 2004
- Drug Organization Investment Project Receives Qualified Praise from Participants: JPMA Survey
April 5, 2004
- OTC NEWS IN BRIEF
April 5, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…